Paper12296458
Acute renal failure and multiple organ dysfunction in the ICU: from renal replacement therapy (RRT) to multiple organ support therapy (MOST).
Ronco C and 1 other. Int J Artif Organs, 2002. Cited by 61 papers, by iCite.
Cite this record
ConductScience Library. Acute renal failure and multiple organ dysfunction in the ICU: from renal replacement therapy (RRT) to multiple organ support therapy (MOST). Papers, record 12296458. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12296458
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Acute renal failure and multiple organ dysfunction in the ICU: from renal replacement therapy (RRT) to multiple organ support therapy (MOST).
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Acute Kidney Injury | Major topic |
| Extracorporeal Circulation | Major topic |
| Multiple Organ Failure | Major topic |
| Renal Replacement Therapy | Major topic |
| Sepsis | Major topic |
| Forecasting | |
| Humans | |
| Intensive Care Units | |
| Water-Electrolyte Balance |
Source PubMed
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 61 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42824696 | Time from acute kidney injury to continuous renal replacement therapy and outcomes in critically ill children. | Clin Kidney J | 2026 | https://conductscience.org/library/papers/42824696 | PubMed |
| 40364014 | Immunomodulation in Pediatric Sepsis: A Narrative Review. | J Clin Med | 2025 | https://conductscience.org/library/papers/40364014 | PubMed |
| 40250871 | Key performance indicators for acute intermittent kidney replacement therapy in critically ill patients: a protocol for a systematic review. | BMJ Open | 2025 | https://conductscience.org/library/papers/40250871 | PubMed |
| 39722012 | Use of extracorporeal blood purification therapies in sepsis: the current paradigm, available evidence, and future perspectives. | Crit Care | 2024 | https://conductscience.org/library/papers/39722012 | PubMed |
| 36817416 | Effect of extracorporeal hemoadsorption in critically ill patients with COVID-19: A narrative review. | Front Immunol | 2023 | https://conductscience.org/library/papers/36817416 | PubMed |
| 35128695 | The role of the ADVanced Organ Support (ADVOS) system in critically ill patients with multiple organ failure. | Artif Organs | 2022 | https://conductscience.org/library/papers/35128695 | PubMed |
| 35011913 | Continuous Renal Replacement Therapy in the Critically Ill Patient: From Garage Technology to Artificial Intelligence. | J Clin Med | 2021 | https://conductscience.org/library/papers/35011913 | PubMed |
| 34513045 | Hemofiltration in Patients with Severe Acute Pancreatitis (Review). | Sovrem Tekhnologii Med | 2020 | https://conductscience.org/library/papers/34513045 | PubMed |
| 33850794 | From Critical Care Nephrology To Critical Care Blood Purification. | J Transl Int Med | 2021 | https://conductscience.org/library/papers/33850794 | PubMed |
| 32676849 | Advanced organ support (ADVOS) in the critically ill: first clinical experience in patients with multiple organ failure. | Ann Intensive Care | 2020 | https://conductscience.org/library/papers/32676849 | PubMed |
| 32095838 | Options in extracorporeal support of multiple organ failure. | Med Klin Intensivmed Notfmed | 2020 | https://conductscience.org/library/papers/32095838 | PubMed |
| 28677045 | Evaluation of an ADVanced Organ Support (ADVOS) system in a two-hit porcine model of liver failure plus endotoxemia. | Intensive Care Med Exp | 2017 | https://conductscience.org/library/papers/28677045 | PubMed |
| 28574107 | Continuous Renal Replacement Therapy: Forty-year Anniversary. | Int J Artif Organs | 2017 | https://conductscience.org/library/papers/28574107 | PubMed |
| 27818750 | Use of high-volume haemodiafiltration in patients with refractory septic shock and acute kidney injury. | Clin Kidney J | 2013 | https://conductscience.org/library/papers/27818750 | PubMed |
| 24929959 | Continuous renal replacement therapy (CRRT) for rhabdomyolysis. | Cochrane Database Syst Rev | 2014 | https://conductscience.org/library/papers/24929959 | PubMed |
| 23271571 | Simplified regional citrate anticoagulation using a calcium-containing replacement solution for continuous venovenous hemofiltration. | J Artif Organs | 2013 | https://conductscience.org/library/papers/23271571 | PubMed |
| 17069660 | Efficacy and safety of a low-flow veno-venous carbon dioxide removal device: results of an experimental study in adult sheep. | Crit Care | 2006 | https://conductscience.org/library/papers/17069660 | PubMed |
| 16542480 | Recent evolution of renal replacement therapy in the critically ill patient. | Crit Care | 2006 | https://conductscience.org/library/papers/16542480 | PubMed |
| 16097050 | Influence of continuous veno-venous hemofiltration on the course of acute pancreatitis. | World J Gastroenterol | 2005 | https://conductscience.org/library/papers/16097050 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/12296458
GET https://conductscience.org/api/papers/v1/12296458/authors